Wolverine Trading’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.8M | Sell |
122,500
-82,800
| -40% | -$9.41M | 0.01% | 768 |
|
|
2025
Q2 | $22.7M | Sell |
205,300
-6,000
| -3% | -$639K | 0.02% | 438 |
|
|
2025
Q1 | $23.6M | Buy |
211,300
+85,700
| +68% | +$8.84M | 0.03% | 358 |
|
|
2024
Q4 | $11.6M | Sell |
125,600
-6,700
| -5% | -$603K | 0.01% | 711 |
|
|
2024
Q3 | $11.1M | Sell |
132,300
-72,800
| -35% | -$5.55M | 0.01% | 645 |
|
|
2024
Q2 | $14.1M | Buy |
205,100
+23,800
| +13% | +$1.59M | 0.01% | 504 |
|
|
2024
Q1 | $13.3M | Buy |
181,300
+4,300
| +2% | +$331K | 0.01% | 551 |
|
|
2023
Q4 | $14.3M | Buy |
177,000
+30,300
| +21% | +$2.36M | 0.02% | 572 |
|
|
2023
Q3 | $11M | Buy |
146,700
+18,300
| +14% | +$1.41M | 0.01% | 591 |
|
|
2023
Q2 | $9.76M | Sell |
128,400
-67,500
| -34% | -$5.38M | 0.01% | 604 |
|
|
2023
Q1 | $16M | Buy |
195,900
+93,300
| +91% | +$7.73M | 0.02% | 400 |
|
|
2022
Q4 | $8.81M | Sell |
102,600
-26,900
| -21% | -$2.13M | 0.01% | 662 |
|
|
2022
Q3 | $8.17M | Sell |
129,500
-25,100
| -16% | -$1.58M | 0.01% | 638 |
|
|
2022
Q2 | $9.66M | Sell |
154,600
-106,300
| -41% | -$6.58M | 0.02% | 525 |
|
|
2022
Q1 | $15.6M | Sell |
260,900
-174,200
| -40% | -$11.1M | 0.02% | 519 |
|
|
2021
Q4 | $31.9M | Buy |
435,100
+103,900
| +31% | +$7.16M | 0.04% | 341 |
|
|
2021
Q3 | $23.5M | Buy |
331,200
+13,200
| +4% | +$927K | 0.03% | 466 |
|
|
2021
Q2 | $21.6M | Buy |
318,000
+23,400
| +8% | +$1.56M | 0.03% | 392 |
|
|
2021
Q1 | $19.3M | Sell |
294,600
-61,000
| -17% | -$3.93M | 0.03% | 408 |
|
|
2020
Q4 | $20.1M | Buy |
355,600
+79,100
| +29% | +$4.77M | 0.03% | 397 |
|
|
2020
Q3 | $17.2M | Buy |
276,500
+34,300
| +14% | +$2.38M | 0.04% | 346 |
|
|
2020
Q2 | $18.1M | Sell |
242,200
-100,700
| -29% | -$7.72M | 0.05% | 276 |
|
|
2020
Q1 | $26M | Buy |
342,900
+1,700
| +0.5% | +$117K | 0.08% | 167 |
|
|
2019
Q4 | $22.2M | Buy |
341,200
+90,300
| +36% | +$5.88M | 0.05% | 330 |
|
|
2019
Q3 | $15.8M | Sell |
250,900
-102,700
| -29% | -$6.71M | 0.05% | 350 |
|
|
2019
Q2 | $23.9M | Sell |
353,600
-32,100
| -8% | -$2.11M | 0.07% | 241 |
|
|
2019
Q1 | $25.1M | Buy |
385,700
+70,800
| +22% | +$4.71M | 0.07% | 204 |
|
|
2018
Q4 | $19.5M | Buy |
314,900
+104,500
| +50% | +$7.3M | 0.06% | 264 |
|
|
2018
Q3 | $16.2M | Sell |
210,400
-66,000
| -24% | -$4.98M | 0.04% | 368 |
|
|
2018
Q2 | $20.8M | Hold |
276,400
| – | – | 0.05% | 241 |
|
|
2018
Q1 | $20.8M | Sell |
276,400
-166,200
| -38% | -$13.2M | 0.05% | 241 |
|
|
2017
Q4 | $31.7M | Buy |
442,600
+61,000
| +16% | +$4.63M | 0.11% | 147 |
|
|
2017
Q3 | $30.9M | Sell |
381,600
-61,000
| -14% | -$4.66M | 0.12% | 146 |
|
|
2017
Q2 | $31.4M | Sell |
442,600
-25,100
| -5% | -$1.67M | 0.14% | 120 |
|
|
2017
Q1 | $31.6M | Buy |
467,700
+117,800
| +34% | +$8.28M | 0.17% | 107 |
|
|
2016
Q4 | $25.1M | Sell |
349,900
-57,100
| -14% | -$4.24M | 0.12% | 158 |
|
|
2016
Q3 | $31.7M | Buy |
407,000
+136,700
| +51% | +$11.1M | 0.15% | 133 |
|
|
2016
Q2 | $22.2M | Buy |
+270,300
| New | +$24M | 0.13% | 149 |
|
Other funds holding GILD
Wolverine Trading's GILD Position: Q3 2025 in Review
Wolverine Trading increased its Gilead Sciences (GILD) stake by 385% in Q3 2025, buying an estimated $3.68M and bringing the position to 40,825 shares worth $4.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1456.
Wolverine Trading first reported a position in GILD in Q2 2016 and has held it in 37 quarters since. The position peaked at $19.6M in Q4 2017. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Wolverine Trading held 40,825 shares of Gilead Sciences worth $4.6M as of Q3 2025.
- Wolverine Trading bought 32,409 Gilead Sciences shares in Q3 2025, an estimated $3.68M.
- Gilead Sciences made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1456 holding.
- Wolverine Trading first reported a position in Gilead Sciences in Q2 2016 and has held it in 37 quarters since.
- Wolverine Trading's Gilead Sciences position peaked at $19.6M in Q4 2017.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.